Federal award (PURCHASE ORDER, fiscal year 2021)
Recipient: CARDINAL HEALTH 108, LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2021-12-21 to 2021-12-31
Current total value of award: $22685.43
Description: SIRTURO IS BEDAQUILINE, SOLD UNDER THE BRAND NAME SIRTURO, IS A MEDICATION USED TO TREAT ACTIVE TUBERCULOSIS.